MicrobeWorld App

appsquarebannerad200x200

Microbes After Hours

microbes-after-hours-logo
Click for "Microbes After Hours" videos

Agar Art Contest 2016

AgarArt-MicrobeWorld-200x200

Featured Image

Featured Video

MWV102featured

Join MicrobeWorld

Supporters

ASM House 200X200

Subscribe via Email

subscribe

AIDS Divisions of 2 Large Drug Makers Form Company to Focus on the Disease

Image
Two of the world’s biggest drug makers last week spun off their divisions that manufacture AIDS drugs and combined them into one company focusing on the disease.

The new company, ViiV Healthcare, will initially be 85 percent controlled by GlaxoSmithKline and 15 percent controlled by Pfizer. With headquarters in London, the company initially has a portfolio of 10 licensed drugs, including some of the earliest, like AZT and lamivudine, and later ones, like maraviroc, with combined sales of about $2.7 billion in 2008. It also has seven drugs in the pipeline.

The companies say they will try to develop new drugs and new formulations of existing ones, like combination doses for children. ViiV Healthcare will also seek partnerships with other companies to develop multidrug cocktails.
 
 

Comments (0)

Collections (0)

 

American Society for Microbiology
2012 1752 N Street, N.W. • Washington, DC 20036-2904 • (202) 737-3600
American Society For Microbiology © 2014   |   Privacy Policy   |   Terms of Use